This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, Y W Articles by Kaye, F J Search for Related Content PubMed PubMed Citation Articles by Kim, Y W Articles by Kaye, F J

 Previous Article  |  Next Article 

Mol Cell Biol. 1994 November; 14(11): 7256-7264

Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein.

NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland.

ABSTRACT

The growth suppressor activities of the RB and p107 products are believed to be mediated by the reversible binding of a heterogeneous family of cellular proteins to a conserved T/E1A pocket domain that is present within both proteins. To study the functional role of these interactions, we examined the properties of cellular retinoblastoma binding protein 2 (RBP2) binding to RB, p107, and the related TATA-binding protein (TBP) product. We observed that although RBP2 bound exclusively to the T/E1A pocket of p107, it could interact with RB through independent T/E1A and non-T/E1A domains and with TBP only through the non-T/E1A domain. Consistent with this observation, we found that a mutation within the Leu-X-Cys-X-Glu motif of RBP2 resulted in loss of ability to precipitate p107, while RB- and TBP-binding activities were retained. We located the non-T/E1A binding site of RBP2 on a 15-kDa fragment that is independent from the Leu-X-Cys-X-Glu motif and encodes binding activity for RB and TBP but does not interact with p107. Despite the presence of a non-T/E1A binding site, however, recombinant RBP2 retained the ability to preferentially precipitate active hypophosphorylated RB from whole-cell lysates. In addition, we found that cotransfection of RBP2 can reverse in vivo RB-mediated suppression of E2F activity. These findings confirm the differential binding specificities of the related RB, p107, and TBP proteins and support the presence of multifunctional domains on the nuclear RBP2 product which may allow complex interactions with the cellular transcription machinery.

This article has been cited by other articles:

• Hayakawa, T., Ohtani, Y., Hayakawa, N., Shinmyozu, K., Saito, M., Ishikawa, F., Nakayama, J.-i. (2007). RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation. GENES CELLS 12: 811-826 [Abstract] [Full Text]  
• Russo, G., Zamparelli, A., Howard, C. M., Minimo, C., Bellan, C., Carillo, G., Califano, L., Leoncini, L., Giordano, A., Claudio, P. P. (2005). Expression of Cell Cycle-Regulated Proteins pRB2/p130, p107, E2F4, p27, and pCNA in Salivary Gland Tumors: Prognostic and Diagnostic Implications. Clin. Cancer Res. 11: 3265-3273 [Abstract] [Full Text]  
• Ahmed, S., Palermo, C., Wan, S., Walworth, N. C. (2004). A Novel Protein with Similarities to Rb Binding Protein 2 Compensates for Loss of Chk1 Function and Affects Histone Modification in Fission Yeast. Mol. Cell. Biol. 24: 3660-3669 [Abstract] [Full Text]  
• Bellan, C., De Falco, G., Tosi, G. M., Lazzi, S., Ferrari, F., Morbini, G., Bartolomei, S., Toti, P., Mangiavacchi, P., Cevenini, G., Trimarchi, C., Cinti, C., Giordano, A., Leoncini, L., Tosi, P., Cottier, H. (2002). Missing Expression of pRb2/p130 in Human Retinoblastomas Is Associated with Reduced Apoptosis and Lesser Differentiation. IOVS 43: 3602-3608 [Abstract] [Full Text]  
• Gracey, A. Y., Troll, J. V., Somero, G. N. (2001). Hypoxia-induced gene expression profiling in the euryoxic fish Gillichthys mirabilis. Proc. Natl. Acad. Sci. USA 98: 1993-1998 [Abstract] [Full Text]  
• Gildea, J. J., Lopez, R., Shearn, A. (2000). A Screen for New Trithorax Group Genes Identified little imaginal discs, the Drosophila melanogaster Homologue of Human Retinoblastoma Binding Protein 2. Genetics 156: 645-663 [Abstract] [Full Text]  
• Cinti, C., Leoncini, L., Nyongo, A., Ferrari, F., Lazzi, S., Bellan, C., Vatti, R., Zamparelli, A., Cevenini, G., osi, G. M. T, Claudio, P. P., Maraldi, N. M., Tosi, P., Giordano, A. (2000). Genetic Alterations of the Retinoblastoma-Related Gene RB2/p130 Identify Different Pathogenetic Mechanisms in and among Burkitt’s Lymphoma Subtypes. Am. J. Pathol. 156: 751-760 [Abstract] [Full Text]  
• Leoncini, L., Bellan, C., Cossu, A., Claudio, P. P., Lazzi, S., Cinti, C., Cevenini, G., Megha, T., Laurini, L., Luzi, P., Orcioni, G. F., Piccioli, M., Pileri, S., Giardino, C., Tosi, P., Giordano, A. (1999). Retinoblastoma-related p107 and pRb2/p130 Proteins in Malignant Lymphomas: Distinct Mechanisms of Cell Growth Control. Clin. Cancer Res. 5: 4065-4072 [Abstract] [Full Text]  
• Magae, J, Wu, C., Illenye, S, Harlow, E, Heintz, N. (1996). Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci. 109: 1717-1726 [Abstract]  
• Chan, S. W., Hong, W. (2001). Retinoblastoma-binding Protein 2 (Rbp2) Potentiates Nuclear Hormone Receptor-mediated Transcription. J. Biol. Chem. 276: 28402-28412 [Abstract] [Full Text]